Global Biological Sample Handling Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Biological Sample Handling Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Biological sample processing is the process of collecting, storing and processing biological samples for further research or use. Biological sample management plays an important role in the drug discovery process and DNA extraction. As such, it is widely used in applications such as drug discovery, forensic investigations, proteomics, and genomics research. The sample is stored in either cold storage or room temperature storage accordingly.

Market Overview:

The latest research study on the global Biological Sample Handling market finds that the global Biological Sample Handling market reached a value of USD 1232.21 million in 2022. It’s expected that the market will achieve USD 1920.52 million by 2028, exhibiting a CAGR of 7.68% during the forecast period.

The impact of the new crown pneumonia epidemic on the biological sample handling industry is divided into two aspects. On the one hand, like most industries, COVID-19 has had an impact on the industrial chain of the biological sample handling industry. On the other hand, it also brings opportunities to the industry.

Due to the global spread of covid-19, downstream applications in the biological sample handling industry have been widely affected. For example, it can have an impact on the entire testing process, laboratory operations and its personnel due to biosecurity concerns. Turnaround time for routine testing may also be affected. In addition, the increase in the number of confirmed cases has negatively affected both the accuracy and availability of biological samples. The sample suffers, which in turn puts many studies in limbo.

In addition, the COVID-19 pandemic has presented challenges to the healthcare industry. Laboratory safety is one of the most important issues for biobanks responsible for collecting, processing, storing and distributing samples from COVID-19 patients. Currently, an unknown number of biobanks are collecting COVID-19 samples and data for researchers to use. However, after the pandemic is over, a large number of these samples will still be stored in biobanks around the world. Biobanks must be prepared through appropriate consent and business planning processes to ensure that these samples are used and not left idle and stored.

Demand drives the market

The growing demand for high-quality samples that can be used in a wide range of applications such as clinical trials, research, and molecular epidemiological studies is driving the growth of the biological sample handling market. In recent years, with the rise and development of translational medicine and precision medicine, many important scientific research results need to be rapidly industrialized to be applied to the clinic as soon as possible, shortening the process from laboratory to hospital bed, so that patients can truly benefit from scientific research results. Driving the demand for high-quality samples. The establishment of high-quality and large-scale biobanks plays an irreplaceable and important role in exploring new treatment approaches for human diseases, developing new diagnosis and treatment methods, and optimizing the allocation of resources for pharmaceutical research and development, and is extremely helpful for improving the efficiency of scientific research.

Professional Restrictions

Biological sample handling requires technicians with relevant experience and knowledge. If executed incorrectly, they can damage entire projects and cost labs thousands of dollars in having to repeat work while wasting precious samples that cannot be recovered. Given increased scrutiny for the accuracy of research data, stricter quality standards in application markets such as clinical testing, forensics and drug discovery, and increased focus on laboratory efficiency, higher demands are being placed on technicians. The lack of professionals may hinder the growth of this market to some extent.

Region Overview:

United States dominated the Biological Sample Handling market in 2021, with a market share of 38.19%.

Company Overview:

Cord Blood Registry is one of the major players operating in the Biological Sample Handling market, holding a share of 9.27% in 2022.

Cord Blood Registry

Founded in 1992, CBR is the largest private newborn stem cell bank in the world, helping parents store more than 925,000 cord blood and cord tissue samples for their children. CBR is dedicated to advancing the clinical application of cord blood and cord tissue stem cells by partnering with institutions to establish FDA-regulated clinical trials for conditions that have no cure today.

Azenta Life Sciences (Brooks Automation)

Azenta is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally.

Segmentation Overview:

By type, Cold Storage segment accounted for the largest share of market in 2021.

Cold Storage

Freezing biological samples at low temperatures (-20ºC, -80ºC to -190°C) is currently the gold standard method for preserving biological samples. Also known as frozen storage and ultra-low temperature frozen storage. Additionally, the temperature range of 2°C to 8°C is often used as a short-term storage option, especially for enzymes, antibodies, and other biological reagents. This is because these materials will remain viable at these refrigerated temperature conditions (when used within the recommended time frame).

Room Temperature Storage

Room Temperature Storage, this temperature-controlled storage typically ranges from 15 degrees Celsius to 30 degrees Celsius. This storage method is suitable for biological materials containing preservatives (including alcohol, formalin, etc.), including specimens and tissue samples.

Application Overview:

The market's largest segment by application is the segment Drug Discovery, with a market share of 40.13% in 2021.

Key Companies in the global Biological Sample Handling market covered in Chapter 3:

Cell&Co BioServices
Fisher BioServices
BioDock
Alliance Pharma PLC
Cryopoint
Clinigen Clinical Supplies Management
ReproCELL
Precision For Medicine
Cord Blood Registry
ProteoGenex
SciSafe
Cryo-Cell
Azenta Life Sciences (Brooks Automation)
Discovery Life Sciences
PrecisionMed
Masy BioServices

In Chapter 4 and Chapter 14.2, on the basis of types, the Biological Sample Handling market from 2018 to 2029 is primarily split into:

Cold Storage
Room Temperature Storage

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Biological Sample Handling market from 2018 to 2029 covers:

Drug Discovery
Forensic Investigation
DNA Extraction
Proteomics and Genomics Studies
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)